Restor3d Archives - Medical Design Sourcing

3 inevitable innovations in materials for 3D printing orthopedics

Restor3d uses metal and polymer 3D printing for orthopedic implants, anatomical models and surgical tools and guides. [Photo courtesy of Formlabs]

3D printing for orthopedics is one of the most promising applications of additive manufacturing for medical devices.

3D printing is already used to manufacture orthopedic implants and tools by device developers as large as Stryker — the world’s biggest orthopedics manufacturer — and startups like Restor3d.

A few key innovations in 3D printing materials will enable even better orthopedic devices in the future.

And it’s not a matter of if, but when, said Restor3d SVP of Product Development Nathan Evans, who identified three next-generation materials advances he’s looking forward to for 3D printing orthopedics.

“I think they’re all going to happen,” he said in an interview with Medical Design & Outsourcing. &#…

January 2024 edition: The Leadership in Medtech issue

Opening the brain’s secret back door: A conversation with Synchron co-founder and CEO Dr. Tom Oxley

How Recor Medical won the renal denervation race for FDA approval

Medtech’s biggest personnel moves of 2023

Leadership and innovation in medtech

Creativity, energy, agility — those are three words Recor Medical CEO Lara Barghout used to describe the culture at the world’s first device developer to win FDA approval for hypertension-treating renal denervation (RDN).

You can add persistence to that list. Ever since its founding in 2009, Recor Medical and its team has been pushing to deliver a safe and effective RDN system. The seemingly long odds got longer as larger competitors pulled the plug on their own programs — or in Medtronic’s case, pushed on despite clinical trial failures and won approval shortly after Recor.

Our annual Leadership in Medtech issue of Medical Design &a…

3D-printed orthopedic implant benefits also present challenges

Restor3d uses metal and polymer 3D printing for orthopedic implants, anatomical models and surgical tools and guides. [Photo courtesy of Formlabs]

3D-printed orthopedic implant personalization and manufacturing abilities introduce new considerations for device developers.

3D-printed orthopedic implants are increasingly being used for patient personalization and features that improve osseointegration.

Faster, better and more affordable additive manufacturing technology is driving that adoption for ortho implant developers and manufacturers like Restor3d.

“The thing I’m most excited about is doubling down on this thesis that people deserve personalized implants — and that it’s actually possible now,” said Nathan Evans, SVP of product development at Restor3d. “Twenty years ago, it wasn’t possible. Ten years ago, people started doing it, but it wasn’t cost-effect…

3D-printed orthopedic implant maker Restor3d completes Conformis acquisition

Restor3d announced today that it completed its previously announced acquisition of Conformis (Nasdaq:CFMS).

The companies completed the deal, announced in June, after Conformis’ stockholders approved it at a special meeting on Aug. 31. As a result, shares of Conformis common stock ceased trading on the Nasdaq prior to market open today, Sept. 5.

Per the terms disclosed in the companies’ initial announcement, Restor3d acquires all outstanding shares of Conformis common stock. The deal includes a purchase price of $2.27 per share. That represents a 96% premium to the closing price on June 22, 2023.

Restor3d said it expected to make the purchase in cash. The 3D-printed orthopedic implant maker offers patient-specific, patient-matched and associated ancillary products. Its expertise comes in the field of 3D printing osseointegrative biomedical materials. The company also offers biomechanics modeling, AI-based planning and design automation tools.…

Restor3d to acquire Conformis for $2.27 per share

Restor3d and Conformis (Nasdaq:CFMS) announced that they entered into a definitive merger agreement.

Under the agreement, Restor3d, a 3D-printed orthopedic company, acquires all outstanding shares of Conformis common stock. The deal includes a purchase price of $2.27 per share. That represents a 96% premium to the closing price on June 22, 2023. Restor3d intends to make the purchase in cash.

“This combination will create a leading personalized 3D-printed medical device company,” said Restor3d CEO Kurt Jacobus. “Together, we share a common belief in the power of personalization. By leveraging the strengths in our respective portfolios around artificial-intelligence-driven implant design, digital automation, and 3D printed osseointegrative biomaterials, we see tremendous opportunity to offer clinically differentiated and cost-effective solutions across the orthopedic landscape, including shoulder, foot & ankle, spine, and large joints.”

…